<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201201098665N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2012-07-04</date_registration>
      <primary_sponsor>Semnan University of Medical Sciences</primary_sponsor>
      <public_title>Comparison effect of two implemented sedation methods (Scale &amp; protocol) by nurses on some consequences of mechanical ventilation in intensive care patients</public_title>
      <acronym></acronym>
      <scientific_title>Comparison effect of two implemented sedation methods (Scale &amp; protocol) by nurses on some consequences of mechanical ventilation in intensive care patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2012-06-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>25</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/9151</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: pneumonia due to mechanical ventilation. Condition 2: mechanical ventilation duration. Condition 3: intra tracheal tube duration. Condition 4: time each of mechanical ventilation mode.</hc_freetext>
      <i_freetext>Intervention 1: after finishing control group sampling, randomly in one section of ICU ward of Alzahra Hospital of Isfahan implement scale and in another part protocol. it is noticeable that selection of patients are based on empty bed not another factors. for elimination of effect of scale use for sedation preparation, scale group is considered. Nursing in scale group based on physician order inject sedation drugs similar to routine group but scale is available for them to use. In this group, sedation score of each patients measured by Richmond scale every 3 hours and then based on score, and physician order, nurse inject sedation drug. Researcher educate Richmond scale to nurses of wards to nurses inject sedation drugs based on scale. Also scale is attaching to wall of patients rooms for observation. Richmond scores of patients document by nurses every 3h.  Allocation of patients in this group is randomly and based on inclusion criteria.  in this group similar to control group physician order is base for drug prescription and followup is continued till attachgment to ventilator or having endotracheal tube, and if done tracheostomy, followup terminate. Intervention 2: at first for determination of routine method effect on outcomes of mechanical ventilation, patients who have inclusion criteria are selected as samples and is done parameteres. at current ways that is done for sadation of patients is including prescription of sedation drugs according to type, dosage, and injection via PRN method as physician order. in routine method, we use of fentanyl and morphine and midazolam via blous and PRN. these drugs is used without any scales and evaluation. nurses in this method have not any scheduled program for drug injection and decision making are based on intuition.  followup duration for patients in this group is untill having endotracheal tube and attachment to ventilator. but if patient undergo tracheostomy followup terminate. drugs dosage for this group is based on physician order and prescription by nurses. Intervention 3: In protocol group, at first agitation score of each patient measured by nurse, and if Richmond score of patient was more than zero, ventilators and other devices are assessed by nurse, and after correction of changeable causes (position …), environment improvement, giving verbal confidence to patient, Midazolam and Fentanyl are inject.  Injection of these drugs is bolus at first and based on calculated dosage for weight and time duration for each drugs in protocol that continue till obtaining relaxation namely Richmond score between 0 to -1. Then continuous infusion of drug based on patient's weight is started. Thereafter control of patient's sedation level is evaluated by nurse at q3h, and based on obtained score, continue drug dose with increase, decrease or unchanged. Goal is obtaining Richmond score between 0 to -1. If necessary to decrease or increase of drug dosage, it is done by increasing or decreasing 25% to primary dosage of drug by nurses (as infusion). Richmond scores are document q3h by nurses. Protocol was designed based on research results from 2005 to current that is according to sedation level evaluation by assessment tools with sedation prescription for achieving to optimal level of sedation that is leading to improved clinical outcomes and improved quality of treatment with sedation. This protocol is confirmed by ward physician. Education of protocol to ward nursed is done by researcher. Also protocol is attached to wall of patient's rooms for observation. Richmond scores for each patient are documented by nurses. Allocation of samples to each group is based on inclusion criteria and randomly.  &#13;
Drugs is including: 1) midazolam Bolus 0.05 mg/kg q5m untill richmond score 0 t0 -1 and after continous infusion of midazolam 0.03 mg/kg/hr. 2) Fentanyl bolus 1/5 microgram/kg q10m till richmond score 0 to -1 and after continous infusion of fentanyl 0.7 microgram/kg/hr. follow up duration is similar to routine and scale group till attachment to ventilator and having endotracheal tube. and if done tracheostomy for patient followup is terminate.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Babamohamadi, Hassan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Semnan, University of Medical Sciences, Nursing and Allied Health Faculty</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3513138111</zip>
        <telephone>+98 23 1335 4190</telephone>
        <email>babamohamadi@sem-ums.ac.ir</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Babamohamadi, Hassan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Semnan, University of Medical Sciences, Nursing and Allied Health Faculty</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3513138111</zip>
        <telephone>+98 23 1335 4190</telephone>
        <email>babamohamadi@sem-ums.ac.ir</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>inclusion criteria: age above18y and under 65y; under mechanical ventilation with Positive pressure; attachment to mechanical ventilation more than 48h; need to sedative drugs in treatment plan.&#13;
exclusion criteria: Tracheostomy; weaning before 24h; using neuromuscular blocker drugs; after CPR; severe hearing loss; pripheral nervous system disorders; addiction; pneumonia before 48h of attchment to mechanical ventilation.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>j18</hc_code>
      <hc_code>j70.9</hc_code>
      <hc_code>y65.8</hc_code>
      <hc_code>z51.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Pneumonia, organism unspecified</hc_keyword>
      <hc_keyword>Respiratory conditions due to unspecified external agent</hc_keyword>
      <hc_keyword>Other specified misadventures during surgical and medical care</hc_keyword>
      <hc_keyword>Other specified medical care</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>after finishing control group sampling, randomly in one section of ICU ward of Alzahra Hospital of Isfahan implement scale and in another part protocol. it is noticeable that selection of patients are based on empty bed not another factors. for elimination of effect of scale use for sedation preparation, scale group is considered. Nursing in scale group based on physician order inject sedation drugs similar to routine group but scale is available for them to use. In this group, sedation score of each patients measured by Richmond scale every 3 hours and then based on score, and physician order, nurse inject sedation drug. Researcher educate Richmond scale to nurses of wards to nurses inject sedation drugs based on scale. Also scale is attaching to wall of patients rooms for observation. Richmond scores of patients document by nurses every 3h.  Allocation of patients in this group is randomly and based on inclusion criteria.  in this group similar to control group physician order is base for drug prescription and followup is continued till attachgment to ventilator or having endotracheal tube, and if done tracheostomy, followup terminate.</i_keyword>
      <i_keyword>at first for determination of routine method effect on outcomes of mechanical ventilation, patients who have inclusion criteria are selected as samples and is done parameteres. at current ways that is done for sadation of patients is including prescription of sedation drugs according to type, dosage, and injection via PRN method as physician order. in routine method, we use of fentanyl and morphine and midazolam via blous and PRN. these drugs is used without any scales and evaluation. nurses in this method have not any scheduled program for drug injection and decision making are based on intuition.  followup duration for patients in this group is untill having endotracheal tube and attachment to ventilator. but if patient undergo tracheostomy followup terminate. drugs dosage for this group is based on physician order and prescription by nurses.</i_keyword>
      <i_keyword>In protocol group, at first agitation score of each patient measured by nurse, and if Richmond score of patient was more than zero, ventilators and other devices are assessed by nurse, and after correction of changeable causes (position …), environment improvement, giving verbal confidence to patient, Midazolam and Fentanyl are inject.  Injection of these drugs is bolus at first and based on calculated dosage for weight and time duration for each drugs in protocol that continue till obtaining relaxation namely Richmond score between 0 to -1. Then continuous infusion of drug based on patient's weight is started. Thereafter control of patient's sedation level is evaluated by nurse at q3h, and based on obtained score, continue drug dose with increase, decrease or unchanged. Goal is obtaining Richmond score between 0 to -1. If necessary to decrease or increase of drug dosage, it is done by increasing or decreasing 25% to primary dosage of drug by nurses (as infusion). Richmond scores are document q3h by nurses. Protocol was designed based on research results from 2005 to current that is according to sedation level evaluation by assessment tools with sedation prescription for achieving to optimal level of sedation that is leading to improved clinical outcomes and improved quality of treatment with sedation. This protocol is confirmed by ward physician. Education of protocol to ward nursed is done by researcher. Also protocol is attached to wall of patient's rooms for observation. Richmond scores for each patient are documented by nurses. Allocation of samples to each group is based on inclusion criteria and randomly.  &#13;
Drugs is including: 1) midazolam Bolus 0.05 mg/kg q5m untill richmond score 0 t0 -1 and after continous infusion of midazolam 0.03 mg/kg/hr. 2) Fentanyl bolus 1/5 microgram/kg q10m till richmond score 0 to -1 and after continous infusion of fentanyl 0.7 microgram/kg/hr. follow up duration is similar to routine and scale group till attachment to ventilator and having endotracheal tube. and if done tracheostomy for patient followup is terminate.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Clinical pneumonia due to mechanical ventilation. Timepoint: first and fourth day of admission. Method of measurement: physician diagnosis.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Mechanical ventilation duration. Timepoint: hour. Method of measurement: from attchment to ventilator until weaning time.</sec_outcome>
      <sec_outcome>Hospitalization time in ICU. Timepoint: hour. Method of measurement: from admission in ICU until discharge time.</sec_outcome>
      <sec_outcome>Intra tracheal tube duration. Timepoint: hour. Method of measurement: from insertion tracheal tube until exiting.</sec_outcome>
      <sec_outcome>Mechanical ventilation modes. Timepoint: hour. Method of measurement: including Spont, SIMV, Bilevel.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Semnan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2012-06-19</approval_date>
        <contact_name>Semnan University of Medical Sciences</contact_name>
        <contact_address>Semnan- Basidj Bolv- Central deputy of Semnan University of Medical Sciences- Research and Technology deputy Semnan  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
